Details der Publikation - epinephrine in COVID-19

Medienart:	Klinische Studie

Erscheinungsjahr:	2021
Erschienen:	2021

Enthalten in:	WHO International Clinical Trials Registry Platform - (2021) vom: 26. Mai Zur Gesamtaufnahme - year:2021

Sprache:	Unbestimmt

Links:	Volltext [kostenfrei]

Themen:	610 Medical Condition: COVID-19, virus identified. COVID-19, virus identified;U07.1 Phase: Phase 2/Phase 3 Recruitment Status: Not yet recruiting Study Type: Interventional

Anmerkungen:	WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2021-05-24, Last updated: 2022-11-24

ICTRP ID:	IRCT20200506047323N8

Förderinstitution / Projekttitel:

PPN (Katalog-ID):	CTG007648405


LEADER	01000caa a22002652 4500
001	CTG007648405
003	DE-627
005	20230425171559.0
007	cr uuu---uuuuu
008	210603s2021 xx \|\|\|\|\|o 00\| \|\|und c
035			\|a (DE-627)CTG007648405
035			\|a (UBBS_Klinische_Studien_WHO)IRCT20200506047323N8
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a und
245	1	0	\|a epinephrine in COVID-19 \|b Evaluation of the effects of epinephrine on the treatment of COVID-19 pneumonia: a randomized clinical trial
264		1	\|c 2021
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2021-05-24, Last updated: 2022-11-24
650		4	\|a Medical Condition: COVID-19, virus identified. COVID-19, virus identified;U07.1
650		4	\|a Study Type: Interventional
650		4	\|a Phase: Phase 2/Phase 3
650		4	\|a Recruitment Status: Not yet recruiting
650		4	\|a 610
773	0	8	\|i Enthalten in \|t WHO International Clinical Trials Registry Platform \|g (2021) vom: 26. Mai
773	1	8	\|g year:2021 \|g day:26 \|g month:05
856	4	0	\|u http://en.irct.ir/trial/56388 \|z kostenfrei \|3 Volltext
912			\|a GBV_CTG
912			\|a SSG-OLC-PHA
951			\|a AR
952			\|j 2021 \|b 26 \|c 05